Your Article Summary
See Latest ArticlesGraves Hyperthyroidism after Stopping Immune Suppressive Therapy in Type 1 Diabetic Islet Cell Recipients with Pretransplant TPO-Autoantibodies
Diabetes Care, 07/02/09
Keymeulen B et al. - Type 1 diabetic recipients of islet cell grafts with pretransplant TPO-autoantibody positivity exhibit a high risk for developing Graves' hyperthyroidism after immune suppressive therapy is discontinued for a failing graft.
Related Articles
Activating Autoantibodies to the Beta-1 Adrenergic and M2 Muscarinic Receptors Facilitate Atrial Fibrillation in Patients With Graves' Hyperthyroidism
JACC - Journal of the American College of Cardiology, 10/05/09
Relevance Score: 68%
Graves' Disease Associated with Primary Systemic Sclerosis
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09
Relevance Score: 65%
Recurrence of Graves' Disease in Thyroglossal Duct Remnants: Relapse After Total Thyroidectomy
Thyroid, 11/19/09
Relevance Score: 44%
Herpes virus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease
European Journal of Endocrinology, 11/19/09
Relevance Score: 43%
Premature hair greying may predict reduced bone mineral density in Graves' disease
Irish Journal of Medical Science, 10/27/09
Relevance Score: 43%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09